4-[[[[6-[(Diethylamino)methyl]-2-naphthalenylmethoxy]carbonyllaminolbenzoic acid NEW

Beijing Hope Pharmaceutical Co., Ltd., established in 2005, is a high-tech enterprise with "chemical drug technology development-Process Optimization-Regulation registration and approval" as its core competence, and has won the title of "China Top 20 Pharmaceutical R&D Company" for several times. Hope Pharma actively builds one-stop service for drug CRO and CDMO, continuously expands its service areas, and establishes good cooperative relations with some leading pharmaceutical companies domestic and abroad. Hope Pharma has over 19 years of experience in project evaluation, innovation-oriented patent around design, pre-clinical development, clinical trial practice, registration, marker authorization, etc.. Our products involve anti-tumor, anti-depressant, anti-epileptic, anxiolytic, cardiovascular and cerebrovascular, digestive system, respiratory system and other indications. In finished products, Hope Pharma has accumulated rich experience in technical platforms such as sustained-release dosage, PLM-PtsE preparation platforms, and transdermal drug delivery, and has long-term accumulation for special reaction types (like nitrification, asymmetric catalysis, low temperature reaction) and chiral drugs. Until now, more than 130 technology transform, over 80 registration approvals and 60+ patents has been finished in Hope(including subsidiaries) for past 19 years, and has been rated as a national high-tech enterprise. Hope Pharma currently has 3 production bases, passed the on-site audit of USFDA and PMDA, and a number of products have obtained CEP certificate and USDMF number, our products well exported to Europe, Japan, South Korea, Taiwan, India and other countries and regions.